Dr Lal PathLabs shares were trading at Rs 2,234.65, up nearly 5 percent from the previous close. The revised price target implies an upside of 8 percent from March 22 closing
Your email address will not be published. Required fields are marked *
Save my name, email, and website in this browser for the next time I comment.
Leave a Comment